vs
Tarsus Pharmaceuticals, Inc.（TARS）与UNITIL CORP（UTL）财务数据对比。点击上方公司名可切换其他公司
UNITIL CORP的季度营收约是Tarsus Pharmaceuticals, Inc.的1.1倍（$161.5M vs $151.7M），UNITIL CORP净利率更高（11.8% vs -5.5%，领先17.3%），Tarsus Pharmaceuticals, Inc.同比增速更快（128.4% vs 26.7%），Tarsus Pharmaceuticals, Inc.自由现金流更多（$13.0M vs $-36.3M），过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高（134.4% vs -4.9%）
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司，专注于眼科、皮肤科等专科领域创新疗法的研发和商业化，主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症，核心市场为美国。
Unitil是一家跨州电力与天然气公用事业公司，业务覆盖美国新罕布什尔州、马萨诸塞州与缅因州。公司最早前身是1849年在缅因州成立的波特兰煤气灯公司，现企业主体于1984年设立，总部位于新罕布什尔州。目前公司总市值约6.8651亿美元，为约10.24万电力客户、超7.59万天然气客户提供服务。
TARS vs UTL — 直观对比
营收规模更大
UTL
是对方的1.1倍
$151.7M
营收增速更快
TARS
高出101.7%
26.7%
净利率更高
UTL
高出17.3%
-5.5%
自由现金流更多
TARS
多$49.3M
$-36.3M
两年增速更快
TARS
近两年复合增速
-4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $151.7M | $161.5M |
| 净利润 | $-8.4M | $19.0M |
| 毛利率 | — | — |
| 营业利润率 | -5.3% | 21.5% |
| 净利率 | -5.5% | 11.8% |
| 营收同比 | 128.4% | 26.7% |
| 净利润同比 | 63.8% | 21.8% |
| 每股收益（稀释后） | $-0.17 | $1.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收TARSUTL
| Q4 25 | $151.7M | $161.5M | ||
| Q3 25 | $118.7M | $101.1M | ||
| Q2 25 | $102.7M | $102.6M | ||
| Q1 25 | $78.3M | $170.8M | ||
| Q4 24 | $66.4M | $127.5M | ||
| Q3 24 | $48.1M | $92.9M | ||
| Q2 24 | $40.8M | $95.7M | ||
| Q1 24 | $27.6M | $178.7M |
净利润TARSUTL
| Q4 25 | $-8.4M | $19.0M | ||
| Q3 25 | $-12.6M | $-300.0K | ||
| Q2 25 | $-20.3M | $4.0M | ||
| Q1 25 | $-25.1M | $27.5M | ||
| Q4 24 | $-23.1M | $15.6M | ||
| Q3 24 | $-23.4M | $0 | ||
| Q2 24 | $-33.3M | $4.3M | ||
| Q1 24 | $-35.7M | $27.2M |
营业利润率TARSUTL
| Q4 25 | -5.3% | 21.5% | ||
| Q3 25 | -12.2% | 6.9% | ||
| Q2 25 | -21.6% | 13.0% | ||
| Q1 25 | -33.5% | 27.0% | ||
| Q4 24 | -36.8% | 22.1% | ||
| Q3 24 | -52.3% | 6.2% | ||
| Q2 24 | -81.6% | 13.0% | ||
| Q1 24 | -136.5% | 24.7% |
净利率TARSUTL
| Q4 25 | -5.5% | 11.8% | ||
| Q3 25 | -10.6% | -0.3% | ||
| Q2 25 | -19.8% | 3.9% | ||
| Q1 25 | -32.1% | 16.1% | ||
| Q4 24 | -34.8% | 12.2% | ||
| Q3 24 | -48.7% | — | ||
| Q2 24 | -81.6% | 4.5% | ||
| Q1 24 | -129.4% | 15.2% |
每股收益（稀释后）TARSUTL
| Q4 25 | $-0.17 | $1.05 | ||
| Q3 25 | $-0.30 | $-0.02 | ||
| Q2 25 | $-0.48 | $0.25 | ||
| Q1 25 | $-0.64 | $1.69 | ||
| Q4 24 | $-0.57 | $0.97 | ||
| Q3 24 | $-0.61 | $0.00 | ||
| Q2 24 | $-0.88 | $0.27 | ||
| Q1 24 | $-1.01 | $1.69 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $417.3M | $15.6M |
| 总债务越低越好 | $72.4M | $670.5M |
| 股东权益账面价值 | $343.4M | $609.6M |
| 总资产 | $562.2M | $2.1B |
| 负债/权益比越低杠杆越低 | 0.21× | 1.10× |
8季度趋势，按日历期对齐
现金及短期投资TARSUTL
| Q4 25 | $417.3M | $15.6M | ||
| Q3 25 | $401.8M | $14.6M | ||
| Q2 25 | $381.1M | $8.5M | ||
| Q1 25 | $407.9M | $10.2M | ||
| Q4 24 | $291.4M | $6.3M | ||
| Q3 24 | $317.0M | $6.3M | ||
| Q2 24 | $323.6M | $2.8M | ||
| Q1 24 | $298.5M | $6.3M |
总债务TARSUTL
| Q4 25 | $72.4M | $670.5M | ||
| Q3 25 | $72.3M | $670.5M | ||
| Q2 25 | $72.1M | $640.7M | ||
| Q1 25 | $72.0M | $642.1M | ||
| Q4 24 | $71.8M | $643.3M | ||
| Q3 24 | $71.7M | $643.3M | ||
| Q2 24 | $71.6M | $511.3M | ||
| Q1 24 | $29.9M | $512.8M |
股东权益TARSUTL
| Q4 25 | $343.4M | $609.6M | ||
| Q3 25 | $335.1M | $597.2M | ||
| Q2 25 | $332.6M | $532.8M | ||
| Q1 25 | $342.5M | $534.1M | ||
| Q4 24 | $224.5M | $512.5M | ||
| Q3 24 | $237.5M | $502.4M | ||
| Q2 24 | $252.2M | $508.8M | ||
| Q1 24 | $275.2M | $510.8M |
总资产TARSUTL
| Q4 25 | $562.2M | $2.1B | ||
| Q3 25 | $534.6M | $1.9B | ||
| Q2 25 | $495.0M | $1.9B | ||
| Q1 25 | $500.8M | $1.9B | ||
| Q4 24 | $377.0M | $1.8B | ||
| Q3 24 | $376.3M | $1.7B | ||
| Q2 24 | $376.8M | $1.7B | ||
| Q1 24 | $349.3M | $1.7B |
负债/权益比TARSUTL
| Q4 25 | 0.21× | 1.10× | ||
| Q3 25 | 0.22× | 1.12× | ||
| Q2 25 | 0.22× | 1.20× | ||
| Q1 25 | 0.21× | 1.20× | ||
| Q4 24 | 0.32× | 1.26× | ||
| Q3 24 | 0.30× | 1.28× | ||
| Q2 24 | 0.28× | 1.00× | ||
| Q1 24 | 0.11× | 1.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.3M | $21.4M |
| 自由现金流经营现金流 - 资本支出 | $13.0M | $-36.3M |
| 自由现金流率自由现金流/营收 | 8.6% | -22.5% |
| 资本支出强度资本支出/营收 | 4.2% | 35.7% |
| 现金转化率经营现金流/净利润 | — | 1.13× |
| 过去12个月自由现金流最近4个季度 | $-22.3M | $-53.8M |
8季度趋势，按日历期对齐
经营现金流TARSUTL
| Q4 25 | $19.3M | $21.4M | ||
| Q3 25 | $18.3M | $15.6M | ||
| Q2 25 | $-29.4M | $42.2M | ||
| Q1 25 | $-20.7M | $52.1M | ||
| Q4 24 | $-22.2M | $23.3M | ||
| Q3 24 | $-8.7M | $26.1M | ||
| Q2 24 | $-14.4M | $49.9M | ||
| Q1 24 | $-37.8M | $26.6M |
自由现金流TARSUTL
| Q4 25 | $13.0M | $-36.3M | ||
| Q3 25 | $16.3M | $-39.0M | ||
| Q2 25 | $-30.4M | $2.0M | ||
| Q1 25 | $-21.2M | $19.5M | ||
| Q4 24 | $-22.3M | $-32.3M | ||
| Q3 24 | $-8.9M | $-31.3M | ||
| Q2 24 | $-15.4M | $13.2M | ||
| Q1 24 | $-38.0M | $6.4M |
自由现金流率TARSUTL
| Q4 25 | 8.6% | -22.5% | ||
| Q3 25 | 13.8% | -38.6% | ||
| Q2 25 | -29.6% | 1.9% | ||
| Q1 25 | -27.1% | 11.4% | ||
| Q4 24 | -33.5% | -25.3% | ||
| Q3 24 | -18.6% | -33.7% | ||
| Q2 24 | -37.8% | 13.8% | ||
| Q1 24 | -137.5% | 3.6% |
资本支出强度TARSUTL
| Q4 25 | 4.2% | 35.7% | ||
| Q3 25 | 1.6% | 54.0% | ||
| Q2 25 | 1.0% | 39.2% | ||
| Q1 25 | 0.8% | 19.1% | ||
| Q4 24 | 0.1% | 43.6% | ||
| Q3 24 | 0.6% | 61.8% | ||
| Q2 24 | 2.5% | 38.3% | ||
| Q1 24 | 0.6% | 11.3% |
现金转化率TARSUTL
| Q4 25 | — | 1.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 10.55× | ||
| Q1 25 | — | 1.89× | ||
| Q4 24 | — | 1.49× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 11.60× | ||
| Q1 24 | — | 0.98× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
